The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction:

Anil Verma1, Nagesh S Anavekar, Alessandra Meris

  • 1Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

Insights

Renal impairment after myocardial infarction (MI) is linked to cardiac structural changes, not reduced systolic function. Diastolic dysfunction may explain the increased risk in these patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Internal Medicine

Background:

  • Renal impairment is a known risk factor for adverse cardiovascular outcomes following myocardial infarction (MI).
  • Understanding the mechanisms linking renal function to cardiac health post-MI is crucial for risk stratification and management.

Purpose of the Study:

  • To investigate whether cardiac structural or functional alterations mediate the heightened risk observed in patients with renal impairment after MI.
  • To identify specific echocardiographic parameters associated with varying levels of renal function.

Main Methods:

  • Echocardiography was performed on 603 post-MI patients with left ventricular (LV) dysfunction and/or heart failure (HF).
  • Patients were stratified by estimated glomerular filtration rate (eGFR).
  • Multivariable Cox regression analyzed the relationship between eGFR, cardiac parameters, and outcomes (death or HF).

Main Results:

  • Reduced eGFR correlated with smaller LV volumes, larger left atrial (LA) volumes, and increased LV mass index (LVMI).
  • LV hypertrophy was more prevalent in patients with reduced eGFR.
  • While systolic function (ejection fraction, right ventricular function) was unaffected by renal function, diastolic parameters (mitral deceleration time) showed associations.
  • LVMI and LA volume were significant independent predictors of adverse outcomes.

Conclusions:

  • Renal impairment after MI is associated with adverse cardiac remodeling (smaller LV, larger LA, increased LVMI), but not with reduced systolic function.
  • Diastolic dysfunction, suggested by altered mitral deceleration time and LA volume, may be a key mediator of the increased risk.
  • These findings highlight the importance of assessing cardiac structure and diastolic function in patients with renal impairment post-MI.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...